Furthermore, the use of BST1 knockout mice to study HIV or SARS-CoV-2 infection may elucidate not only the neurological consequences of these viral infections but also validate BST1 as a therapeutic target for these diseases. This evidence concerns the gene BST1 and viral infectious disease.